RGTI Stock Analysis: Rigetti Computing | NASDAQ
Computer Hardware | NASDAQ, USA | Market Cap: 6.148m USD | 12M Return: 4.7% | US76655K1034 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 328M
Qual. Beats: 0
Rev. Trend: -56.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 5.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Rigetti Computing (RGTI) designs, builds, and operates full-stack quantum computers based on superconducting quantum processors, serving commercial, government, defense, and academic customers across the U.S., U.K., Europe, and Asia. Founded in 2013 and headquartered in Berkeley, California, the company went public on NASDAQ in April 2021 and currently sits in the mid-cap range.
The company sells both on-premises quantum processing units (QPUs) and cloud-based access to its systems under a Quantum Computing-as-a-Service (QCaaS) model. Its hardware lineup includes the Novera 9-qubit and 5-qubit QPUs, the 36-qubit Cepheus-1-36Q multi-chip system, and the 84-qubit Ankaa-3 quantum computer, all built on its proprietary Ankaa-class architecture.
Beyond hardware, Rigetti offers a quantum cloud services platform supporting public and private cloud integration, the QCS Outpost system management software, Rigetti Foundry Services for fabricating superconducting quantum chips for third-party research, and professional services covering algorithm development, benchmarking, and quantum application programming. Superconducting qubits remain one of the more mature and heavily funded modalities in the broader quantum computing sector, competing with trapped-ion, neutral-atom, and photonic approaches.
- Government defense contracts drive quantum computing revenue
- Competition from IBM and Google intensifies in quantum race
- ATM equity offerings dilute shareholders amid high cash burn
| Net Income: -238.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.14 > 0.02 and ΔFCF/TA -3.21 > 1.0 |
| NWC/Revenue: 2.32k% < 20% (prev 5.34k%; Δ -3.02k% < -1%) |
| CFO/TA -0.09 > 3% & CFO -60.7m > Net Income -238.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (333.2m) vs 12m ago 11.72% < -2% |
| Gross Margin: -2.73% > 18% (prev 40.57%; Δ -43.30% > 0.5%) |
| Asset Turnover: 2.08% > 50% (prev 1.24%; Δ 0.83% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.48 (Total Current Assets 414.4m - Total Current Liabilities 105.1m) / Total Assets 648.2m |
| B: -1.22 (Retained Earnings -790.5m / Total Assets 648.2m) |
| C: -0.15 (EBIT TTM -97.2m / Avg Total Assets 642.5m) |
| D: 4.85 (Book Value of Equity 537.4m / Total Liabilities 110.8m) |
| Altman-Z'' = 3.23 = A |
| DSRI: 1.31 (Receivables 3.87m/1.75m, Revenue 13.4m/7.92m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.01 (AQ_t 0.23 / AQ_t-1 0.23) |
| SGI: 1.68 (Revenue 13.4m / 7.92m) |
| TATA: -0.27 (NI -238.7m - CFO -60.7m) / TA 648.2m) |
| Beneish M = -2.30 (Cap -4..+1) = BBB |
As of August 15, 2026, the stock is trading at USD 18.82 with a total of 16,913,725 shares traded. Over the past week, the price has changed by +4.91%, over one month by +16.82%, over three months by -2.34% and over the past year by +4.67%.
Current recommended Stop Loss: 17.10 (which is 9.1% or 1.4 ATR below the current price).
Rigetti Computing has received a consensus analysts rating of 4.83. Therefore, it is recommended to buy RGTI.
- StrongBuy: 5
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 28.8 | 53.1% |
P/S = 460.4224
P/B = 10.9614
Revenue TTM = 13.4m USD
EBIT TTM = -97.2m USD
EBITDA TTM = -87.2m USD
Long Term Debt = 5.04m USD (estimated: total debt 7.70m - short term 2.66m)
Short Term Debt = 2.66m USD (from shortTermDebt, last quarter)
Debt = 7.70m USD (from shortLongTermDebtTotal, last quarter) (leases 7.70m already included)
Net Debt = -386.0m USD (calculated: Debt 7.70m - CCE 393.7m)
Enterprise Value = 5.76b USD (6.15b + Debt 7.70m - CCE 393.7m)
Interest Coverage Ratio = unknown (Ebit TTM -97.2m / Interest Expense TTM 0.0)
EV/FCF = -65.79x (Enterprise Value 5.76b / FCF TTM -87.6m)
FCF Yield = -1.52% (FCF TTM -87.6m / Enterprise Value 5.76b)
FCF Margin = -655.9% (FCF TTM -87.6m / Revenue TTM 13.4m)
Net Margin = -1.79k% (Net Income TTM -238.7m / Revenue TTM 13.4m)
Gross Margin = -2.73% ((Revenue TTM 13.4m - Cost of Revenue TTM 13.7m) / Revenue TTM)
Gross Margin QoQ = 42.58% (prev -28.11%)
Tobins Q-Ratio = 8.89 (Enterprise Value 5.76b / Total Assets 648.2m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 7.70m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -76.8m (EBIT -97.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.94 (Total Current Assets 414.4m / Total Current Liabilities 105.1m)
Debt / Equity = 0.01 (Debt 7.70m / totalStockholderEquity, last quarter 537.4m)
Debt / EBITDA = 4.43 (negative EBITDA) (Net Debt -386.0m / EBITDA -87.2m)
Debt / FCF = 4.41 (negative FCF - burning cash) (Net Debt -386.0m / FCF TTM -87.6m)
Total Stockholder Equity = 509.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -37.15% (Net Income -238.7m / Total Assets 648.2m)
RoE = -46.82% (Net Income TTM -238.7m / Total Stockholder Equity 509.8m)
RoCE = -18.87% (EBIT -97.2m / Capital Employed (Equity 509.8m + L.T.Debt 5.04m))
RoIC = -14.08% (negative operating profit) (NOPAT -76.8m / Invested Capital 545.2m)
WACC = 15.02% (E(6.15b)/V(6.16b) * Re(15.04%) + D(7.70m)/V(6.16b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 15.04% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 92.48 | Cagr: 41.80%
[DCF] Fair Price = unknown (Cash Flow -87.6m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.47 | # QB: 0
Revenue Correlation: -56.36 | Revenue CAGR: -14.06% | SUE: 0.02 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.05 | Chg30d=+0.19% | Revisions=-57% | Analysts=8
EPS current Year (2026-12-31): EPS=-0.19 | Chg30d=-0.65% | Revisions=-44% | GrowthEPS=-16.0% | GrowthRev=+228.1%
EPS next Year (2027-12-31): EPS=-0.21 | Chg30d=-2.44% | Revisions=-44% | GrowthEPS=-11.0% | GrowthRev=+89.6%
[Analyst] Revisions Ratio: -63% (up=2, down=14)